behavior/neurological
|
• neither salvinorin A nor salvinorinyl-2-propionate induce analgesia
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Oprk1tm1Jep targeted mutation 1, John E Pintar MGI:4413460 |
||||||||||||||||||||
| Summary |
4 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• neither salvinorin A nor salvinorinyl-2-propionate induce analgesia
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• resistant to agonist U50,488-induced hypoactivity
|
|
• resistant to agonist U50,488-induced analgesia as measured by a failure to exhibit increased warm water tail-flick latency
|
|
• resistant to agonist U50,488-induced dopamine release in nucleus accumbens care and shell
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• fail to develop place aversion after systemic injection of the KOR agonist U50,488
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• U50,488 analgesic response is abolished compared to in wild-type mice
• however, improgan analgesic response is normal
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


